Search Results 741-750 of 18383 for Lactation

  1. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

    - Women who are lactating or breastfeeding, or pregnant. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 10/9 ...

  2. A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma - Mayo Clinic

    Lactating females who plan to breastfeed their infants. Sexually active patients of reproductive potential who have not agreed to use an effective ...

  3. Publications - Allison C. Rosenthal, D.O. - Mayo Clinic

    ... Lactating Breast in a Patient with Hodgkin Lymphoma. J Nucl Med Technol. 2024 Jun 5; 52 (2):177-178 Epub 2024 June 05. View PubMed; Monick S, Rosenthal A ...

  4. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

    Pregnant or lactating females. Inability to swallow tablets. Previously identified allergy or hypersensitivity to components of the study treatment ...

  5. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    Female subjects who are lactating must discontinue nursing prior to the first dose of study treatment and must refrain from nursing throughout the treatment ...

  6. Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease - Mayo Clinic

    Subject is pregnant or lactating at the time of signing the consent. Malignant neoplasm (other than adequately treated non-melanoma skin cancer or in situ ...

  7. Riluzole in Spinal Cord Injury Study - Clinical Trials

    Lactating at screening visit; Subject is currently using, and will continue to use for the next 14 days any of the following medications which are classified ...

  8. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    Pregnant or nursing (lactating) women Other protocol-defined inclusion/exclusion criteria may apply. Participating Mayo Clinic locations. Study statuses ...

  9. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    If female, the patient is pregnant or lactating. Known allergy or hypersensitivity to any component of the study drug. Patients with history of Stevens ...

  10. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

    Pregnancy, lactation, or inability or unwillingness to use medically acceptable forms of contraception if pregnancy is a risk. Any history of allergic ...